# A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors

> **NCT06037317** · PHASE1 · RECRUITING · sponsor: **Shouyao Holdings (Beijing) Co. LTD** · enrollment: 38 (estimated)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** SY-3505

## Key facts

- **NCT ID:** NCT06037317
- **Lead sponsor:** Shouyao Holdings (Beijing) Co. LTD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-30
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-05-30
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2024-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06037317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06037317, "A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06037317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*